Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9-THC

Cell Biochemistry and Function

Volumn 32, Issue 7, 2014, Pages 612-619

  Coskun, Zeynep Mine ^a,b   Bolkent, Sema ^b  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cannabinoid receptors; Gene expression; Oxidative stress; Type 2 diabetes; 9 THC

Indexed keywords

RATTUS;

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CATALASE; DRONABINOL; GLUTATHIONE; NICOTINAMIDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

AGONISTS; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; MALE; METABOLISM; OXIDATIVE STRESS; PANCREAS; PANCREAS DUCT; PANCREAS ISLET; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; CANNABINOID RECEPTOR AGONISTS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DRONABINOL; GLUTATHIONE; ISLETS OF LANGERHANS; MALE; NIACINAMIDE; OXIDATIVE STRESS; PANCREAS; PANCREATIC DUCTS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

EID: 84913597825     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3058     Document Type: Article

References (48)

1. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2011; 8: 228-236.
2. Li F, Tang H, Xiao F, et al. Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice. Molecules 2011; 16: 9912-9924.
3. Baburao Jain A, Anand JV. Vitamin E, its beneficial role in diabetes mellitus (DM) and its complications. J Clin Diagn Res 2012; 6: 1624-1628.
4. Stadler K. Oxidative stress in diabetes. Adv Exp Med Biol 2012; 771: 272-287.
5. Ávila Dde L, Araújo GR, Silva M, et al. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. Arch Med Res 2013; 44: 194-202.
6. Kassab A, Piwowar A. Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie 2012; 94: 1837-1848.
7. Chen J, Errico SL, Freed WJ. Reactive oxygen species and p38 phosphorylation regulate the protective effect of delta9-tetrahydrocannabinol in the apoptotic response to NMDA. Neurosci Lett 2005; 389: 99-103.
8. Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564.
9. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61-65.
10. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 2008; 153: 199-215.
11. Herkenham M, Lynn AB, Johnson MR, et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563-583.
12. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997; 74: 129-80.
13. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161-202.
14. Li C, Jones PM, Persaud SJ. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. Pharmacol Ther 2011; 129: 307-320.
15. Jesudason D, Wittert G. Endocannabinoid system in food intake and metabolic regulation. Curr Opin Lipidol 2008; 19: 344-348.
16. Doyle ME. The role of the endocannabinoid system in islet biology. Curr Opin Endocrinol Diabetes Obes 2011; 18: 153-158.
17. Juan-Picó P, Fuentes E, Bermúdez-Silva FJ, et al. Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. Cell Calcium 2006; 39: 155-162.
18. Bermúdez-Siva FJ, Serrano A, Diaz-Molina FJ, et al. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol 2006; 531: 282-284.
19. Romero-Zerbo SY, Garcia-Gutierrez MS, Suárez J, et al. Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycemia and a lean phenotype in adult mice. J Neuroendocrinol 2012; 4: 1106-1119.
20. Zhang F, Hong S, Stone V, et al. Expression of cannabinoid CB1 receptors in models of diabetic neuropathy. J Pharmacol Exp Ther 2007; 323: 508-515.
21. Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol 2013; 8: 608-620.
22. Masiello P, Broca C, Gross R, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998; 47: 224-229.
23. Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. Academic Press: London, 1971.
24. Ledwozyw A, Michalak J, Stepien A, et al. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986; 155: 275-283.
25. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
26. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
27. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
28. Havel PJ, Hahn TM, Sindelar DK, et al. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 2000; 49: 244-252.
29. Coskun ZM, Bolkent S. Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats. Acta Histochem 2014; 116: 112-116.
30. Shinde SN, Dhadke VN, Suryakar AN. Evaluation of oxidative stress in type 2 diabetes mellitus and follow-up along with vitamin E supplementation. Indian J Clin Biochem 2011; 26: 74-77.
31. Koch JE. Delta (9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 2001; 68: 539-543.
32. Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry 2001; 178: 107-15.
33. Mandal TK, Das NS. Effect of delta-9-tetrahydrocannabinol on altered antioxidative enzyme defense mechanisms and lipid peroxidation in mice testes. Eur J Pharmacol 2009; 607: 178-87.
34. Long LE, Chesworth R, Huang XF, et al. A behavioural comparison of acute and chronic delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Int J Neuropsychopharmacol 2010; 13: 861-876.
35. Ranasinghe P, Perera S, Gunatilake M, et al. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. Pharmacognosy Res 2012; 4: 73-79.
36. Sefi M, Fetoui H, Soudani N, et al. Artemisia campestris leaf extract alleviates early diabetic nephropathy in rats by inhibiting protein oxidation and nitric oxide end products. Pathol Res Pract 2012; 208: 157-162.
37. Cota D, Marsicano G, Lutz B, et al. Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 2003; 27: 289-301.
38. Verty AN, Evetts MJ, Crouch GJ, et al. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology 2011; 36: 1349-1358.
39. Li C, Bowe JE, Huang GC, et al. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. Diabetes Obes Metab 2011; 13: 903-910.
40. Kanter M, Aktas C, Erboga M. Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem Toxicol 2012; 50: 719-725.
41. Srinivasan S, Pari L. Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem Biol Interact 2012; 195: 43-51.
42. Chen J, Lee CT, Errico S, et al. Protective effects of delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death. Brain Res Mol Brain Res 2005; 134: 215-225.
43. Pinto CE, Moura E, Serrão MP, et al. Effect of (-)-delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice. Braz J Med Biol Res 2010; 43: 325-329.
44. Coskun ZM, Sacan O, Karatug A, et al. Regulation of oxidative stress and somatostatin, cholecystokinin, apelin gene expressions by ghrelin in stomach of newborn diabetic rats. Acta Histochem 2013; 115: 740-747.
45. Bermúdez-Silva FJ, Suárez J, Baixeras E, et al. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008; 51: 476-87.
46. Li C, Bowe JE, Jones PM, et al. Expression and function of cannabinoid receptors in mouse islets. Islets 2010; 2: 293-302.
47. Tharp WG, Lee YH, Maple RL, et al. The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochem Biophys Res Commun 2008; 372: 595-600.
48. Nakata M, Yada T. Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors. Regul Pept 2008; 145: 49-53.